Abstract:Introduction Influenza A virus (IAV) infection predisposes to subsequent bacterial superinfection in the lungs. Streptococcus pneumoniae (Sp) is the main bacteria involved in this co-infection process and promotes a greater pneumonia severity. Because alveolar macrophages (AM) are critical in maintaining alveoli homeostasis, we suspect an IAV-induced dysfunction of the lung granulocyte macrophages stimulating colony factor (GM-CSF) production that drives the AM function. The aim of the study is (i) to examine if a defective GM-CSF signaling could be evidenced during IAV infection and, (ii) to assess whether administration of GM-CSF protects mice from Sp superinfection. Methods We compared GM-CSF production in bronchoalveolar lavage (BAL) from IAV infected mice and human. c57BL/6J mice were infected by a mild inoculum of influenza A virus (IAV, H3N2, 10 PFU) by intranasal route (IN). GM-CSF concentration in human BAL was obtained from patients with PCR-confirmed influenza infection and a BAL performed within the four firth days of ICU admission. Next, we performed a bioinformatic analysis based on publicly available AM transcriptomic datasets collected in IAV-infected mice and Csf2 (colony stimulating factor 2)-/- mice. From Csf2-/- mice, we defined genes that are altered when the GM-CSF instruction is defective. Using the transcriptome dataset of AM from IAV-infected mice (and control) we assessed whether AM presented a GM-CSF defective signature. Finally, IAV-infected mice were treated by GM-CSF (IN, 10 μg/mouse) at day 0, 2- and 4-days post-infection (dpi), and superinfected at dpi 7 by Sp (IN, SP1 strain). We monitored weight, survival and AM count. Results A lung GM-CSF production was observed in BAL of IAV-infected patient, but not in mice. In AM collected from IAV-infected mice, nearly all the genes whose expression reflect the lack of GM-CSF instruction were up regulated ( n = 25/28). Moreover, AM count dropped drastically after IAV-infection: AM represented only 35% from baseline AM count in BAL at dpi 7. However, IAV-induced AM depletion was significantly less important in mice treated with GM-CSF (62% from baseline count). Results were similar when studying AM count in BAL or lung homogenate. Finally, GM-CSF administration in IAV-infected mice reduced mortality by 50% of Sp – superinfection (preliminary data). Conclusion It is likely that there are alterations of the GM-CSF instruction post-IAV infection that prevents efficient AM immune function, as reveal by the murine models. Consistently, GM-CSF administration prevents mAMs depletion and mortality due to bacterial superinfection in IAV-infected mice. These data underline the potential protective role of GM-CSF during influenza infection.

GM-CSF in the Lung Protects Against Lethal Influenza Infection

GM-CSF shields IAV-infected mice from bacterial superinfection

Protective Effects of Recombinant Human Granulocyte Macrophage Colony Stimulating Factor on H1N1 Influenza Virus-Induced Pneumonia in Mice.

Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome

Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease

Bacterial Colonization Dampens Influenza-Mediated Acute Lung Injury Via Induction of M2 Alveolar Macrophages

Progranulin Decreases Susceptibility to Streptococcus Pneumoniae in Influenza and Protects Against Lethal Coinfection.

Local GM-CSF–Dependent Differentiation and Activation of Pulmonary Dendritic Cells and Macrophages Protect against Progressive Cryptococcal Lung Infection in Mice

Basic Fibroblast Growth Factor Protects Against Influenza A Virus-Induced Acute Lung Injury by Recruiting Neutrophils.

Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain

Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies

Influenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells through HGF/c-Met and TGF-α/EGFR signaling

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice

Alveolar epithelial cells orchestrate DC function in murine viral pneumonia

Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection

Host-derived lipids orchestrate pulmonary γδ T cell response to provide early protection against influenza virus infection

Delayed Angiopoietin‐2 Blockade Reduces Influenza‐induced Lung Injury and Improves Survival in Mice

Gasdermin D promotes influenza virus-induced mortality through neutrophil amplification of inflammation

G‐CSFR antagonism reduces mucosal injury and airways fibrosis in a virus‐dependent model of severe asthma

Genetically engineered macrophages expressing IFN-γ restore alveolar immune function in scid mice

Evaluation of porcine GM-CSF during PRRSV infection in vitro and in vivo indicating a protective role of GM-CSF related with M1 biased activation in alveolar macrophage during PRRSV infection